首页> 美国卫生研究院文献>Current Developments in Nutrition >The Clinical Effectiveness and Cost Effectiveness of Bariatric Metabolic Surgery for Obese with Poorly Controlled Type 2 Diabetes Patients In Malaysia - A Study Protocol
【2h】

The Clinical Effectiveness and Cost Effectiveness of Bariatric Metabolic Surgery for Obese with Poorly Controlled Type 2 Diabetes Patients In Malaysia - A Study Protocol

机译:肥胖代谢不良的2型糖尿病患者的肥胖代谢疗法的临床疗效和成本效益-研究方案

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Bariatric Surgery is a major breakthrough in diabetes care. Complete remission is attainable in a great percentage of patients. However, there is slow progress in this procedure in Malaysia. With the overwhelming rate of obesity and diabetes in the country, the potential advantage of this treatment modality is underestimated. Conventional diabetes care only controls 22% of the diabetics and healthcare expenditure has ballooned due to complications costs amounting to at least RM 2 billion in a year eating up 10% of the government's budget on healthcare. Furthermore, this burden will increase in the next decades as diabetes is predicted to increase by 69% by 2030. While this procedure is beneficial, it is an expensive intervention with risks of complications. This raises the question of whether bariatric surgery is cost-effective in the context of this country? Evidence must be available to decision-makers weighing the risk-benefit ratio of the procedure. This study aims to assess the clinical effectiveness and cost-effectiveness of bariatric surgery in managing obesity among the Malaysian population. It will specifically investigate the short term and long-term effects of the procedure investigating anthropometric and metabolic disease blood indicator changes while assessing direct, indirect costs, QALYs gained and complications associated with the procedure.
机译:减肥手术是糖尿病护理的一项重大突破。很大一部分患者可以完全缓解。但是,马来西亚的这一程序进展缓慢。由于该国肥胖和糖尿病的泛滥成灾,这种治疗方式的潜在优势被低估了。常规的糖尿病护理仅控制了22%的糖尿病患者,而由于并发症成本一年至少达到20亿林吉特,导致政府支出的10%吞噬了政府的医疗保健预算,因此医疗保健支出激增。此外,由于预计到2030年糖尿病会增加69%,因此这种负担将在未来几十年内增加。尽管这种方法是有益的,但它是一种昂贵的干预措施,存在并发症的风险。这就提出了一个问题,在这个国家的背景下减肥手术是否具有成本效益?决策者必须获得证据,权衡该程序的风险收益率。这项研究旨在评估减肥手术在管理马来西亚人群肥胖症方面的临床效果和成本效益。它将专门研究该程序的短期和长期影响,调查人体测量学和代谢性疾病血液指标的变化,同时评估直接,间接费用,获得的QALY和与该程序相关的并发症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号